English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1668]
News [6601]
Articles [109]
Editorials [4]
Conferences [191]
elearning [21]
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
ASH 2025: Study connects Agent Orange exposure to earlier and more severe cases of myelodysplastic syndrome
Cancer loses its sense of time to avoid stress responses
Cancer loses its sense of time to avoid stress responses
ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers
ASH 2025: Developed antibody boosts immune response against blood cancers and solid cancers
CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer development
CDT1 overexpression suppresses DNA replication and induces DNA damage, suggesting a mechanism for cancer...
Research reveals how disordered protein regions contribute to cancer-causing condensates
Research reveals how disordered protein regions contribute to cancer-causing condensates
Researchers crack gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with cholesterol inhibitors in neuron-infiltrated cases
Researchers crack gastric cancer’s ‘metabolic code’: Tumour growth slowed by 65%, plus a 6.3-fold kill rate with...
New tool reveals hidden metabolic weakness in blood cancers
New tool reveals hidden metabolic weakness in blood cancers
Scientists find cancer weak spot in backup DNA repair system
Scientists find cancer weak spot in backup DNA repair system
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
ASH 2025: AI uncovers how DNA architecture failures trigger blood cancer
Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy
Pathway discovered to make the most common breast cancer tumour responsive to immunotherapy
<12345…661>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top